Granules India Limited — Updates, 24-01-2025: Press Release

Granules India Ltd. reported a revenue of INR 11,377 Mn for Q3FY25, reflecting a 2% decline year-over-year, despite an 18% quarter-over-quarter growth. EBITDA decreased by 8% YoY to INR 2,303 Mn, while PAT fell 6% YoY to INR 1,176 Mn. The revenue breakdown showed a significant shift, with North America now constituting 77% of total revenue, up from 66% in the same quarter last year. The company paused production at its Gagillapur plant in September 2024 for risk assessments related to US FDA observations but resumed in October. A strong return on capital employed (ROCE) at 16.4% indicates operational efficiency, supported by net debt of INR 8,289 Mn, reflecting a healthy net debt to EBITDA ratio of 0.90. The company remains focused on enhancing quality and compliance, especially through ongoing improvements at the Gagillapur facility and expansion at GLS, signaling a positive outlook driven by North America’s performance.